ClinicalTrials.Veeva

Menu

Clinical Outcome of Extracorporeal Shock Wave Therapy in Patient With Axillary Web Syndrome

T

Taichung Veterans General Hospital

Status

Enrolling

Conditions

Breast Cancer
Lymphedema
Extracorporeal Shock Wave Therapy
Axillary Web Syndrome

Treatments

Device: Low energy ESWT

Study type

Interventional

Funder types

Other

Identifiers

NCT05082597
CF21163B

Details and patient eligibility

About

Axillary web syndrome(AWS) is common complication of breast cancer surgery. Overall, AWS affects more than a half of the patient receiving axillary lymph node dissection. The symptoms of AWS include pain, limited function and range of motion. Geater risk of secondary lymphedema was found if the patient developed AWS during the first postoperative year.

ESWT was used for treating myofascial pain for decades. Low energy ESWT combined with complex decongestive therapy had a benefit on shoulder joint ROM and skin thickness improvement in patients with BCRL in recently studies. Investigators wonder if ESWT can also be applied to patients with axillary web syndrome for increasing ROM and relieving pain.

The aim of this study was to evaluate the therapeutic effects of low energy ESWT in patients with axillary web syndrome.

Enrollment

30 estimated patients

Sex

Female

Ages

20 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Axillary web syndrome patient
  2. Unilateral breast cancer and received related operation(mastectomy/ALND/SLND)
  3. Completion of beast related chemotherapy or radiotherapy
  4. Age with 20-65 years old

Exclusion criteria

  1. Ongoing metastasis or recurrence of the breast cancer
  2. Other cancer history
  3. Lymphatic transplantation or reconstruction
  4. Wound, infection or trauma over affected arm
  5. Coagulopathy or poor circulation
  6. Pregnancy
  7. Oral anticoagulant using

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

30 participants in 1 patient group

ESWT
Experimental group
Description:
Receive low energy extracorporeal shock wave therapy
Treatment:
Device: Low energy ESWT

Trial contacts and locations

1

Loading...

Central trial contact

Yuan Yang Cheng, MD,PhD; Yu Chun Lee, MD, MHA

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems